Trials / Completed
CompletedNCT00291499
Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand
Clinical Evaluation of Condrosulf 800 mg in the Treatment of Symptomatic OA of the Hand: a 6-month, Double-blind, Placebo Controlled Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 163 (actual)
- Sponsor
- IBSA Institut Biochimique SA · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The goal of the present study is to investigate the effectiveness of Condrosulf® 800 mg tablets vs. placebo once a day for 6 months in the symptomatic treatment of finger joint osteoarthritis. Primary endpoints of the study are the evaluation of global spontaneous pain (Huskisson's Visual Analogue Scale: VAS) and the score of Dreiser's algo-functional index (FIHOA) during the treatment with the tested product, Condrosulf®, versus placebo.
Detailed description
The goal of the present study is to investigate the effectiveness of Condrosulf® 800 mg tablets vs. placebo once a day for 6 months in the symptomatic treatment of finger joint osteoarthritis in 160 randomised patients. Primary endpoints: Primary endpoints of the study are the evaluation of global spontaneous pain (Huskisson's Visual Analogue Scale: VAS) and the score of Dreiser's algo-functional index (FIHOA) during the treatment with the tested product, Condrosulf®, versus placebo. Secondary endpoints are: Efficacy evaluation: Global impression of efficacy expressed by the patient and the physician (VAS), Grip strength (measured manometrically); Morning stiffness duration; Consumption of Paracetamol; Tolerability (4-point verbal scale); Adverse Events occurring during the treatment period; Other parameters:Treatment compliance; Biological markers of arthritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chondroitin 4&6 sulfate (Condrosulf) | 800 mg/day for 6 months |
| OTHER | Placebo | 800 mg placebo/day for 6 months |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2009-12-01
- Completion
- 2010-08-01
- First posted
- 2006-02-14
- Last updated
- 2021-03-04
- Results posted
- 2021-03-04
Source: ClinicalTrials.gov record NCT00291499. Inclusion in this directory is not an endorsement.